Tsukushi is a novel prognostic biomarker and correlates with tumor-infiltrating B cells in non-small cell lung cancer
Open accessAbstract
might be a potential prognostic biomarker involved in tumor immune infiltration in NSCLC.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Hepatic and plasma levels of tsukushi are strongly stimulated by stimuli that augment thermogenesis and energy expenditure, including adrenergic agonists and cold exposure.
“Hepatic and plasma levels of this hepatokine are strongly stimulated by stimuli that augment thermogenesis and energy expenditure (including adrenergic agonists and cold exposure) [78,88,89].”
From Adipokines, Myokines, and Hepatokines: Crosstalk and Metabolic Repercussions (2021) · cites this paper as [89]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 45 · Cited by 17
- Authors
- Huang, H., Zhang, D., Fu, J., Zhao, L., Li, D., Sun, H., Liu, X., Xu, J., Tian, T., Zhang, L., Liu, Y., Zhang, Y., & Zhao, Y.
- Affiliations
- Harbin Medical University (CN)
- Corresponding author
- Zhao, Yashuang
- ORCID
- Venue
- Aging
- Publisher
- Impact Journals, LLC
- Published
- 2021-01-10
- Volume
- 13
- Issue
- 3
- Pages
- 4428-4451
- ISSN
- 1945-4589 (ISSN-L)
- PMC
- PMC7906171
- OpenAlex
- W3118962805
- Cited by
- 17
- References
- 45
- Citations by year
- 2026: 3 · 2025: 3 · 2023: 4 · 2022: 5 · 2021: 1 · 2020: 1
- FWCI
- 0.91
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- cc-by
- Locations
- Aging (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Lung Cancer Research Studies
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Ferroptosis and cancer prognosis
- Keywords
- Tsukushi, prognostic factors, non-small cell lung cancer, tumor-infiltrating B cells, tumor immune infiltration, antitumor immunity
- MeSH terms
- Adenocarcinoma of Lung, B-Lymphocytes, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Humans, Lung Neoplasms, Prognosis, Proteoglycans, Survival Rate, Lymphocytes, Tumor-Infiltrating, Databases, Genetic, Intercellular Signaling Peptides and Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
